FDA Admits Knee Device Approval Was Compromised
The U.S. Food and Drug Administration's clearance of a ReGen Biologics Inc. knee device was compromised by Capitol Hill pressure and a lack of safety data, the FDA revealed in a...To view the full article, register now.
Already a subscriber? Click here to view full article